Background: In clinical settings, the time varying analysis of gait data relies heavily on the experience of the individual(s) assessing these biological signals. Though three dimensional kinematics are recognised as time varying waveforms (1D), exploratory statistical analysis of these data are commonly carried out with multiple discrete or 0D dependent variables. In the absence of an a priori 0D hypothesis, clinicians are at risk of making type I and II errors in their analyis of time varying gait signatures in the event statistics are used in concert with prefered subjective clinical assesment methods. The aim of this communication was to determine if vector field waveform statistics were capable of providing quantitative corroboration to practically significant differences in time varying gait signatures as determined by two clinically trained gait experts. Methods: The case study was a left hemiplegic Cerebral Palsy (GMFCS I) gait patient following a botulinum toxin (BoNT-A) injection to their left gastrocnemius muscle. Findings: When comparing subjective clinical gait assessments between two testers, they were in agreement with each other for 61% of the joint degrees of freedom and phases of motion analysed. For tester 1 and tester 2, they were in agreement with the vector-field analysis for 78% and 53% of the kinematic variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together and then compared to the vectorfield analysis, they were in agreement for 83% of the time varying kinematic variables analysed.
Introduction
There is little argument that three dimensional joint kinematics and force data are time varying (1D) vector waveforms. In clinical settings, the commonplace analysis of time varying clinical gait data is subjective, relying heavily on the experience of the individual(s) assessing these biological signals. Though recognised as waveform data, the exploratory statistical analyses of clinical gait data are generally carried out using a variety of discrete, zero-dimensional (0D) dependent variables (i.e., min, max, mean, etc.) in an attempt to best model the time varying (1D) characteristic of these signals.
When gait waveforms are objectively assessed to determine the efficacy of a treatment in a research setting, the statistical analyses of these three dimensional or multi-component vectors are generally modelled with 0D variance about fixed means within pre-defined joint degrees of freedom and phases of the gait cycle (Ebert et al., 2013) . From a scientific viewpoint, if no a priori 0D hypotheses is presented, and the 1D gait waveform is modelled with 0D randomness, researchers are predisposed to making regional focus biases in their statistical analysis (Pataky et al., 2013) and virtually guaranteed to make type I errors in their assessment of discrete (0D) time points within the waveform (Pataky et al., 2016b) . They are also at-risk of making type II errors at every other time point within the time series (Pataky et al., 2013) . This places practical limitations on the type(s) of quantitative analyses a clinician can use to formulate reliable clinical assessments associated with the effectiveness or efficacy of a given treatment or intervention.
Following the development of vector-field analysis for the mapping of human brain activity and anatomy (Friston et al., 1995; Friston et al., 2007) , these statistics have been validated for the assessment of three dimensional, time varying (1D) kinematic and force vectors (Pataky, 2016a) in research settings. From a research standpoint, the development of vector-field statistics for the analysis of gait can mitigate the probability Clinical Biomechanics 41 (2017) [87] [88] [89] [90] [91] of making type I and II errors in the statistical assessment of human movement data (Pataky et al., 2013) . The utility of vector-field statistics for the analysis of time varying gait data within clinical gait settings is also apparent. Specifically, vector-field statistics have the potential to assist in the objective analysis of these complex time varying signals (i.e., pre-versus post-versus normative), helping to improve the inter-and intra-clinician analysis reliability of these data.
The primary aim of this communication was to compare the subjective analysis of pre-versus post-clinical gait data between two trained clinical gait experts and a vector-field statistical method. We predict vector-field statistics will corroborate with the subjective clinical analysis of both clinical gait experts as the statistical methodology considers the within-dataset time varying variability in its entirety. A secondary aim of this communication was to conduct an exploratory analyses of the same data using a pre-versus post-0D scalar analysis. The motivation for these secondary analyses are for completeness, and to highlight some potential limitations associated with the 0D analysis of clinical gait data in an exploratory type setting.
Methods
A single paediatric participant (4.4 years, 121 cm, 26.4 kg) classified as spastic type left hemiplegic Cerebral Palsy (GMFCS I) was the case study chosen for these analyses. A seven camera motion capture system operating at 100 Hz (Vicon MX) recorded three dimensional (3D) kinematic marker trajectories during walking gait four days prior to and four weeks following a single botulinum toxin (BoNT-A) injection to the left gastrocnemius muscle. During each testing session, 20 individual trials were recorded at the participant's self-selected walking speed.
The kinematic marker set and three dimensional lower-limb kinematic modelling procedures, which used a Calibrated Anatomical System Technique (CAST) and functional hip and knee joint axes and/ or centres was used to estimate the participant-specific lower limb kinematics. Full modelling procedures have been describe previously (Besier et al., 2003) . Aligning with ISB recommendations, the anatomical degrees of freedom for each joint were flexion/extension, ab/adduction and internal/external rotation (Besier et al., 2003; Ebert et al., 2013) . For simplicity, a condensed clinical gait report, which contained the three dimensional kinematics of the left and right hip, knee and ankle separated into their anatomical degrees of freedom (n = 18) was used for analyses ( Fig. 1,  pane 1 ). All data were time normalised to 100% stride. See Appendix A for full three dimensional kinematic gait report.
Three analyses were performed. First, two testers with 11 and 7 years' experience analysing paediatric cerebral palsy gait independently assessed the mean time varying joint kinematics of the participant pre-versus post-BoNT-A injection (Fig. 1, pane 1) . The testers were instructed to report all clinically meaningful kinematic differences within the stance and swing phase of the gait cycle. They were also asked to report when within the normalised gait cycles these differences were observed, as well as the direction of these changes. See Appendix B for written instructions provided to testers.
Second, statistical parametric mapping (SPM), specifically a Hotelling's T 2 test (α = 0.05) were used to assess the three dimensional (i.e., 3-Component) time varying (1D) vectors of the hip, knee and ankle joint. By modelling the hip, knee and ankle as a 3-Component vector, the flexion/extension, ab/adduction, internal/external kinematic waveforms, as well as collinearities between them are all modelled statistically. If significant differences were observed, the three dimensional time varying (1D) vector was separated into its vector components, and analysed as time varying (1D) scalar waveforms. Conceptually, these analyses would be comparable to using a post hoc analysis when a main effect is identified with a three factor ANOVA. See Appendix C for a two component time varying (1D) vector analysis. Table 1 Agreement between both testers and SPM through the stance and swing phase of the participant's stride. Agreement between both testers and SPM was assessed through the stance and swing phase of the participant's stride. Agreement was operationally defined as when the same pre-versus post-kinematic difference was observed, when the observed difference was in the same direction and when the timing of this difference was in alignment (≥80% of the observed difference). In addition, for each degree of freedom, local pre-versus post-0D difference (local minima and maxima) during the stance and swing phase of a single stride. Agreement between both testers and vector-field analysis were assessed throughout the stance and swing phase of a stride. Agreement was operationally defined as when the same pre-versus post-kinematic difference was observed, when the observed difference was in the same direction and when the timing of this difference was in alignment (≥80% of the observed difference).
Third, the discrete 0D statistical analysis of 18 independent kinematic waveforms pre-versus post-BoNT-A injection were performed. To accomplish this, the local minimum and maximum of each kinematic waveform within the stance and swing phases of the gait cycle were analysed. All 0D scalar variables were analysed using independent sample t-tests (α = 0.05). As these analyses were exploratory in nature without any a priori hypotheses, protected post hoc adjustments for multiple comparisons were not made. It should be noted that pre-versus normative and post-versus normative vector-field statistical analyses can be performed. Additionally, any alpha level can be chosen for these statistical analyses of these waveform data (i.e., α = 0.05, 0.01, 0.10). By using random field theory within the vector field statistical approach, alpha is protected for the analysis of time varying and three dimensional or n-Component vector waveforms.
Results
The time varying (1D) vector analysis of the three dimensional (i.e., 3-Component) vectors for the left and right hip, knee and ankle were statistically different pre-versus post-BoNT-A injection (Fig. 1, pane  2) . The time varying (1D) scalar analysis of each joint degree of freedom, pre-versus post-BoNT-A injection (Fig. 1, pane 3 ) revealed statistical differences for all but two lower limb joint degrees of freedom. These include left hip flexion/extension and right ankle plantar/dorsiflexion.
When comparing the subjective assessments of the two testers, they were in agreement with each other for 61% of the joint degrees of freedom and phases of motion assessed (Table 1) . For tester 1, they were in agreement with the vector-field analysis for 78% of the variables analysed. For tester 2, they were in agreement with the vector-field analysis for 53% of the variables analysed. When the subjective analyses of tester 1 and tester 2 were pooled together, they were in agreement with the vector field analysis for 83% of the time varying kinematic variables analysed. This is practically significant as clinical gait reports are generally analysed in teams with or two more gait experts.
For the 0D analysis, only three of the 72 discrete variables assessed did not reported pre-versus post-statistical differences (Table 1) . These included left ankle inversion/eversion and right ankle plantar/dorsiflexion during stance, and right knee internal/external rotation during swing. For 22 of the 36 gait phase and joint degree of freedom combinations analysed, both the local minimum and local maximum were significantly different.
Discussion
Results showed that for over 80% of the lower limb kinematic variables analysed, one of the two clinical gait experts' subjective analyses of these data were in agreement with the SPM vector analyses. We feel this is a practically meaningful result as clinical gait case studies are generally analysed in teams of two or more gait experts. We acknowledge that the kinematic variables the testers did not agree upon during their analysis may not have translated to differences in their clinical interpretation(s)/recommendation(s) of the data. These results clearly show vector-field statistics can provide objective, clinically meaningful information for the analysis of time varying kinematic data. We feel this is a meaningful step forward for the objective, exploratory analysis of clinical gait data, as clinicians are provided an objective statistical tool from which best practice clinical decision making can be built from.
Vector-field statistics offers clinicians an objective analysis framework to work from when formulating conclusions and/or making clinical decisions from pre-versus post-versus normative clinical gait data. What is interesting to note is that both researchers, and SPM reported increases in left ankle dorsi-flexion following the BoNT-A injection, which aligns with previous research studies utilising a vector field statistical approach to assess the influence of BoNT-A as a clinical treatment for a similar same populations (Nieuwenhuys et al., 2016) . However, SPM did not identify the same differences in knee extension kinematics, which have been documented previously (Nieuwenhuys et al., 2016) . In addition, for this clinical case study, SPM identified statistical difference at the hip, knee and ankle, which were not observed previously (Nieuwenhuys et al., 2016) . These results highlight the importance of using an exploratory time varying analysis method like vector field statistics in clinical settings, as each case study is patient and treatment specific.
We appreciate that vector field statistics may be initially perceived by some researchers or clinicians as a computationally cumbersome or a time expensive analysis tool. In reality, vector field statistics simplifies the analysis of time varying data. Therein, 1D analyses of a time varying waveform can be performed in single step versus researchers attempting to pull out multiple 0D variables that best characterises the time varying behaviour of the signal. An additional, and underappreciated benefit for using vector field statistics method over a 0D statistical approach is that time does not need to be spent consciously deliberating on the rational/ method(s) to protect, or not protect alpha. For example, it could be argued that for the 0D scalar analysis presented in this manuscript, alpha should have been protected for four comparisons (i.e., two maximums and two minimums). Our rational for not protecting alpha is that clinical gait analyses are exploratory in nature. This type of argument is avoided when using SPM, as random field theory and the temporal smoothness of the time varying signals are used to define critical-t thresholds while protecting alpha.
As the focus of this communication was to explore vector-field statistics as a clinical gait analysis tool, future research is recommended to assess whether this statistical approach may alter or influence the clinical decision making for, and/or assessment of, interventions like orthopaedic surgery, BoNT-A treatment, casting, etc. In addition, we encourage researchers to investigate the utility of vector field statistics for the clinical assessment of joint moments, joint power and joint work pre-versus post-intervention(s).
